Filing Details
- Accession Number:
- 0001179110-19-005372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-01 20:11:48
- Reporting Period:
- 2017-12-18
- Accepted Time:
- 2019-05-01 20:11:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926326 | Omnicell Inc | OMCL | Electronic Computers (3571) | 943166458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1227556 | A Randall Lipps | C/O Omnicell, Inc. 590 E.middlefield Mountain View CA 94043 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-18 | 35,879 | $51.24 | 280,613 | No | 4 | S | Indirect | In Trust with Wife |
| Common Stock | Acquisiton | 2019-04-29 | 24,282 | $0.00 | 201,084 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-29 | 1,409 | $79.62 | 199,675 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-29 | 2,600 | $79.62 | 197,075 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-29 | 4,100 | $79.62 | 192,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-29 | 3,407 | $79.62 | 189,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-29 | 1,766 | $79.62 | 187,802 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-29 | 11,000 | $78.28 | 176,802 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-29 | 5,000 | $79.59 | 275,613 | No | 4 | S | Indirect | In Trust with Wife |
| Common Stock | Disposition | 2019-04-29 | 36,296 | $0.00 | 140,506 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2019-04-29 | 36,296 | $0.00 | 311,909 | No | 4 | J | Indirect | In Trust with Wife |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | In Trust with Wife |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | In Trust with Wife |
| No | 4 | J | Direct | |
| No | 4 | J | Indirect | In Trust with Wife |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options NQ (Right to Buy) | Disposition | 2019-04-29 | 13,282 | $0.00 | 13,282 | $25.08 |
| Common Stock | Stock Options NQ (Right to Buy) | Disposition | 2019-04-29 | 11,000 | $0.00 | 11,000 | $27.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-04 | 2024-02-03 | No | 4 | M | Direct |
| 0 | 2017-02-04 | 2026-02-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 176,802 | Direct | |
| Common Stock | 316,492 | Indirect | In Trust with Wife |
| Common Stock | 7,776 | Indirect | In Trust for Children |
Footnotes
- Shares held in trust with Mr. Lipps' wife.
- Shares held in trust for the benefit of Mr. Lipps' children.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.
- As originally reported in a Form 4 filed on February 22, 2019, the reporting person sold 20,000 shares on February 22, 2019. Due to an administrative error, the sales were reported as a reduction to shares held directly by Mr. Lipps, however the sales were actually sold from shares held in trust with Mr. Lipps' wife. The balances of shares held directly by Mr. Lipps and shares held in trust with Mr. Lipps' wife have been corrected accordingly in this Form 4.
- The price reported in Column 4 is the average price of $79.6160. The sold price range between $76.94 to $77.93. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the average price of $79.6160. The sold price range between $77.96 to $78.9150. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the average price of $79.6160. The sold price range between $79.00 to $79.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the average price of $79.6160. The sold price range between $80.18 to $81.18. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the average price of $79.6160. The sold price range between $81.20 to $81.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the average price of $78.2831. The sold price range between $78.00 to $79.04. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the average price of $79.5940. The sold price range between $76.89 to 81.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Transfer from shares held directly by Mr. Lipps to shares held in trust with Mr. Lipps' wife.
- Due to administrative errors, the balance of shares held in trust for the benefit of Mr. Lipps' children was incorrectly reported in prior Form 4s as 14,549 shares; this balance has been adjusted to reflect the corrected balance of 7,776 shares.
- The price reported in Column 4 is the average price of $51.2419. The sold price range between $51.2361 to $51.9333. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction is being reported late due to an inadvertent administrative error.
Billionaire Hedge Funds
